Advertisement
Canada markets close in 4 hours 8 minutes
  • S&P/TSX

    21,669.01
    -71.19 (-0.33%)
     
  • S&P 500

    5,062.86
    +1.04 (+0.02%)
     
  • DOW

    37,898.87
    +163.76 (+0.43%)
     
  • CAD/USD

    0.7238
    -0.0015 (-0.21%)
     
  • CRUDE OIL

    85.67
    +0.26 (+0.30%)
     
  • Bitcoin CAD

    85,470.33
    -3,635.81 (-4.08%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,402.50
    +19.50 (+0.82%)
     
  • RUSSELL 2000

    1,966.05
    -9.65 (-0.49%)
     
  • 10-Yr Bond

    4.6530
    +0.0250 (+0.54%)
     
  • NASDAQ

    15,893.75
    +8.73 (+0.05%)
     
  • VOLATILITY

    18.59
    -0.64 (-3.33%)
     
  • FTSE

    7,820.36
    -145.17 (-1.82%)
     
  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     
  • CAD/EUR

    0.6807
    -0.0017 (-0.25%)
     

MariMed Board of Directors Appoints Edward Gildea as Chairman and Jon Levine as Chief Executive Officer

MariMed Inc.
MariMed Inc.

NORWOOD, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- MariMed, Inc. (CSE: MRMD), (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator (“MSO”), today announced its Board of Directors (the “Board”) has appointed Edward Gildea as Chairman of the Board and Jon Levine as Chief Executive Officer. Mr. Gildea has served as an independent director of the Company since 2013. Mr. Levine, co-founder and President of MariMed, has served as Interim CEO since the December passing of co-founder, Chairman, and CEO Bob Fireman.

Following its search process for the Company’s permanent CEO, the Board concluded Mr. Levine was most qualified to help MariMed achieve the mission that he and Mr. Fireman created as co-founders over a decade ago.

Edward Gildea commented, “Jon’s deep industry experience, his tenured and proven leadership of the Company, and his clear vision for its future, are unparalleled and will serve MariMed’s shareholders very well. The Board looks forward to providing Jon the support he needs to lead the continued implementation of the Company’s strategic plan.”

ADVERTISEMENT

“I am humbled at the opportunity to lead MariMed as CEO and am particularly thankful to the Board for entrusting me to continue the mission that drove Bob and me to create this great company,” said Jon Levine. “We have built a strong, profitable business while improving people’s lives every day. I look forward to navigating MariMed’s future alongside the greatest team in the cannabis industry.”

About MariMed
MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies, Nature’s Heritage, InHouse, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy. For additional information, visit www.marimedinc.com.

Investor Relations Contact:
Steve West
Vice President, Investor Relations
Email: ir@marimedinc.com
Phone: (781) 277-0007

Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007